# A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma

> **NCT06377111** · PHASE1 · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 12 (estimated)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **DIETARY_SUPPLEMENT:** C-PAN
- **BIOLOGICAL:** Nivolumab
- **BIOLOGICAL:** Ipilimumab

## Key facts

- **NCT ID:** NCT06377111
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-24
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06377111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06377111, "A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06377111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*